Showing results (81-90 of 140) with videos related to
Sort By:
Pageof 14
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 4, 2022
Phenotypical screening on metastatic PRCC-TFE3 fusion translocation renal cell carcinoma organoids reveals potential therapeutic agentsChuanzhen Cao, Xiaomei Lan, Bingqing Shang, et al.International Journal of Antimicrobial Agents|December 11, 2023
Metagenomics next-generation sequencing (mNGS) reveals emerging infection induced by Klebsiella pneumoniaeniaeShuang Wan, Aiping Zhou, Rongrong Chen, et al.Frontiers in Microbiology|December 18, 2018
Transcriptional Approach for Decoding the Mechanism of rpoC Compensatory Mutations for the Fitness Cost in Rifampicin-Resistant Mycobacterium tuberculosisZhihong Xu, Aiping Zhou, Jiawei Wu, et al.Iscience|May 31, 2023
Exploration of the immunogenetic landscape of hyperprogressive disease after combined immunotherapy in cancer patientsCaifeng Gong, Wen Zhang, Yongkun Sun, et al.Tuberculosis (Edinburgh, Scotland)|May 5, 2015
Differential expression of miRNAs and their relation to active tuberculosisZhihong Xu, Aiping Zhou, Jinjing Ni, et al.Journal of Gastrointestinal Oncology|November 18, 2024
Regorafenib monotherapy as the later-line treatment for elderly patients with metastatic colorectal cancer: a multicenter real-world studyJinglong Huang, Caifeng Gong, Zhichao Jiang, et al.Genomics, Proteomics & Bioinformatics|August 17, 2017
CYP2A6 Polymorphisms Associate with Outcomes of S-1 Plus Oxaliplatin Chemotherapy in Chinese Gastric Cancer PatientsLin Yang, Shanshan Zou, Chang Shu, et al.Hepatology International|April 7, 2021
Anlotinib in the treatment of advanced hepatocellular carcinoma: an open-label phase II study (ALTER-0802 study)Yongkun Sun, Aiping Zhou, Wen Zhang, et al.Journal of Fungi (Basel, Switzerland)|June 26, 2024
In Vitro Activitiy of Rezafungin in Comparison with Anidulafungin and Caspofungin against Invasive Fungal Isolates (2017 to 2022) in ChinaSimin Yang, Feifei Wan, Min Zhang, et al.Urologic Oncology|January 25, 2016
Body mass index and age are additional prognostic factors in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitorsYan Song, Chunxia Du, Wen Zhang, et al.Pageof 14